Logo image of AKBM.OL

AKER BIOMARINE ASA (AKBM.OL) Stock Price, Forecast & Analysis

Europe - Euronext Oslo - OSL:AKBM - NO0010886625 - Common Stock

97.3 NOK
+0.8 (+0.83%)
Last: 1/21/2026, 3:59:57 PM

AKBM.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap8.53B
Revenue(TTM)265.70M
Net Income(TTM)-34.10M
Shares87.70M
Float9.35M
52 Week High100.8
52 Week Low43.65
Yearly Dividend42.95
Dividend Yield0%
EPS(TTM)-3.72
PEN/A
Fwd PE40.35
Earnings (Next)02-12
IPO2020-07-06
Sector
GICS SectorConsumer Staples
GICS IndustryFood Products
GICS IndustryGroupFood, Beverage & Tobacco
GICS SubIndustryPackaged Foods & Meats
AKBM.OL short term performance overview.The bars show the price performance of AKBM.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

AKBM.OL long term performance overview.The bars show the price performance of AKBM.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of AKBM.OL is 97.3 NOK. In the past month the price increased by 6.51%. In the past year, price increased by 48.46%.

AKER BIOMARINE ASA / AKBM Daily stock chart

AKBM.OL Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to AKBM.OL. When comparing the yearly performance of all stocks, AKBM.OL is one of the better performing stocks in the market, outperforming 82.95% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AKBM.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AKBM.OL. AKBM.OL has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKBM.OL Financial Highlights

Over the last trailing twelve months AKBM.OL reported a non-GAAP Earnings per Share(EPS) of -3.72. The EPS decreased by -115.95% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.56%
ROE -22.75%
Debt/Equity 1.07
Chartmill High Growth Momentum
EPS Q2Q%-100%
Sales Q2Q%15.21%
EPS 1Y (TTM)-115.95%
Revenue 1Y (TTM)2.31%

AKBM.OL Forecast & Estimates

9 analysts have analysed AKBM.OL and the average price target is 86.7 NOK. This implies a price decrease of -10.89% is expected in the next year compared to the current price of 97.3.

For the next year, analysts expect an EPS growth of 70% and a revenue growth -14.74% for AKBM.OL


Analysts
Analysts77.78
Price Target86.7 (-10.89%)
EPS Next Y70%
Revenue Next Year-14.74%

AKBM.OL Ownership

Ownership
Inst Owners5.57%
Ins Owners6.14%
Short Float %N/A
Short RatioN/A

About AKBM.OL

Company Profile

AKBM logo image Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus and currently employs 249 full-time employees. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

Company Info

AKER BIOMARINE ASA

Oksenoyveien 10, P.O. Box 496

Lysaker AKERSHUS NO

Employees: 249

AKBM Company Website

AKBM Investor Relations

Phone: 4724130000

AKER BIOMARINE ASA / AKBM.OL FAQ

Can you describe the business of AKER BIOMARINE ASA?

Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus and currently employs 249 full-time employees. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.


Can you provide the latest stock price for AKER BIOMARINE ASA?

The current stock price of AKBM.OL is 97.3 NOK. The price increased by 0.83% in the last trading session.


What is the dividend status of AKER BIOMARINE ASA?

AKBM.OL does not pay a dividend.


What is the ChartMill technical and fundamental rating of AKBM stock?

AKBM.OL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in AKER BIOMARINE ASA be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AKBM.OL.


What is AKER BIOMARINE ASA worth?

AKER BIOMARINE ASA (AKBM.OL) has a market capitalization of 8.53B NOK. This makes AKBM.OL a Mid Cap stock.


Can you provide the ownership details for AKBM stock?

You can find the ownership structure of AKER BIOMARINE ASA (AKBM.OL) on the Ownership tab.